<div id=toc></div>

# Table of Contents

- [q-bio.GN](#q-bio.GN) [Total: 1]
- [q-bio.QM](#q-bio.QM) [Total: 8]
- [eess.IV](#eess.IV) [Total: 1]
- [q-bio.PE](#q-bio.PE) [Total: 1]


<div id='q-bio.GN'></div>

# q-bio.GN [[Back]](#toc)

### [1] [Single-cell sequencing of trophoblasts in preeclampsia and chemical hypoxia in BeWo b30 cells reveals EBI3, COL17A1, miR-27a-5p, and miR-193b-5p as hypoxia-response markers](https://arxiv.org/abs/2510.01935)
*Evgeny Knyazev,Timur Kulagin,Ivan Antipenko,Alexander Tonevitsky*

Main category: q-bio.GN

TL;DR: 本研究通过整合早发型子痫前期患者胎盘组织分析和体外缺氧模型，鉴定出EBI3、COL17A1、hsa-miR-27a-5p和hsa-miR-193b-5p作为子痫前期中滋养细胞缺氧的关键分子标志物，并发现氧喹啉衍生物比CoCl2提供更生理相关的体外缺氧模型。


<details>
  <summary>Details</summary>
Motivation: 子痫前期影响2-8%的妊娠，以胎盘缺氧和HIF通路激活为特征，尤其是在早发型子痫前期中。整合患者组织分析与实验模型可能揭示滋养细胞缺氧的共同分子标志物。

Method: 分析10例早发型子痫前期、7例晚发型子痫前期及对照胎盘的scRNA-seq数据，鉴定滋养细胞亚群。使用CoCl2和氧喹啉衍生物处理BeWo b30细胞诱导缺氧，进行RNA和小RNA测序分析mRNA和microRNA变化，使用PROGENy推断通路活性。

Result: scRNA-seq显示早发型子痫前期缺氧通路激活最强，EVT在滋养细胞群中活性最高。EBI3、FN1和COL17A1在胎盘组织和OD处理细胞中均上调。鉴定出hsa-miR-27a-5p和hsa-miR-193b-5p在实验条件和PE胎盘囊泡中均升高。

Conclusion: EBI3、COL17A1、hsa-miR-27a-5p和hsa-miR-193b-5p是子痫前期中滋养细胞缺氧的标志物。氧喹啉衍生物比CoCl2提供更生理相关的体外缺氧模型，这一整合方法推进了对子痫前期病理生理学的理解并提出了候选治疗靶点。

Abstract: Background. Preeclampsia (PE) complicates 2-8% of pregnancies and is marked
by placental hypoxia and HIF-pathway activation, especially in early-onset PE
(eoPE). Integrating patient tissue analyses with experimental models may reveal
common molecular markers of trophoblast hypoxia.
  Methods. We analyzed scRNA-seq data from 10 eoPE, 7 late-onset PE (loPE), and
corresponding control placentas, identifying villous cytotrophoblast (VCT),
syncytiotrophoblast (SCT), and extravillous trophoblast (EVT) subpopulations.
BeWo b30 cells were treated for 24 h with CoCl2 (300 $\mu$M) or an oxyquinoline
derivative (OD, 5 $\mu$M) to induce hypoxia. RNA and small RNA sequencing
quantified mRNA and microRNA changes. PROGENy inferred pathway activities.
  Results. ScRNA-seq revealed highest hypoxia pathway activation in eoPE, with
EVT showing maximum activity among trophoblast populations. Nine genes were
upregulated across all trophoblast types in eoPE: EBI3, CST6, FN1, RFK,
COL17A1, LDHA, PKP2, RPS4Y1, and RPS26. In vitro, OD induced more specific
hypoxia responses than CoCl2, with 1,284 versus 3,032 differentially expressed
genes respectively. Critically, EBI3, FN1, and COL17A1 showed concordant
upregulation in both placental tissue and OD-treated cells, while CoCl2
treatment produced opposite expression patterns. MicroRNA analysis identified
hsa-miR-27a-5p and hsa-miR-193b-5p as consistently elevated in both
experimental conditions and previously reported in PE placental vesicles. We
also identified isoforms of hsa-miR-9-5p and hsa-miR-92b-3p as
hypoxia-associated in trophoblast.
  Conclusions. EBI3, COL17A1, hsa-miR-27a-5p, and hsa-miR-193b-5p emerge as
trophoblast hypoxia markers in PE. Oxyquinoline derivatives offer a more
physiologically relevant in vitro hypoxia model than CoCl2. This integrated
approach advances understanding of PE pathophysiology and suggests candidate
therapeutic targets.

</details>


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [2] [To Remember, To Adapt, To Preempt: A Stable Continual Test-Time Adaptation Framework for Remote Physiological Measurement in Dynamic Domain Shifts](https://arxiv.org/abs/2510.01282)
*Shuyang Chu,Jingang Shi,Xu Cheng,Haoyu Chen,Xin Liu,Jian Xu,Guoying Zhao*

Main category: q-bio.QM

TL;DR: 本文提出PhysRAP框架，通过生理相关参数冻结策略防止灾难性遗忘，并通过前瞻性梯度修改策略解决过适应问题，实现远程光电容积描记术(rPPG)的稳定连续测试时适应(CTTA)。


<details>
  <summary>Details</summary>
Motivation: 现有rPPG方法难以弥合源域和目标域之间的差距，而传统测试时适应(TTA)方法假设目标域静止，无法应对动态环境中持续变化的领域偏移，导致灾难性遗忘和过适应问题。

Method: 1. 生理相关参数冻结策略：通过评估模型对当前域的不确定性来分离生理相关和领域相关参数，在适应过程中冻结生理相关参数；2. 前瞻性梯度修改策略：前瞻性地适应未来域，并用获得的梯度修改当前适应过程。

Result: 大量实验表明该方法在领域偏移情况下具有最先进的性能表现。

Conclusion: PhysRAP框架能够记住过去、适应当前并预测未来，有效解决了rPPG测量中的连续测试时适应问题。

Abstract: Remote photoplethysmography (rPPG) aims to extract non-contact physiological
signals from facial videos and has shown great potential. However, existing
rPPG approaches struggle to bridge the gap between source and target domains.
Recent test-time adaptation (TTA) solutions typically optimize rPPG model for
the incoming test videos using self-training loss under an unrealistic
assumption that the target domain remains stationary. However, time-varying
factors like weather and lighting in dynamic environments often cause continual
domain shifts. The erroneous gradients accumulation from these shifts may
corrupt the model's key parameters for physiological information, leading to
catastrophic forgetting. Therefore, We propose a physiology-related parameters
freezing strategy to retain such knowledge. It isolates physiology-related and
domain-related parameters by assessing the model's uncertainty to current
domain and freezes the physiology-related parameters during adaptation to
prevent catastrophic forgetting. Moreover, the dynamic domain shifts with
various non-physiological characteristics may lead to conflicting optimization
objectives during TTA, which is manifested as the over-adapted model losing its
adaptability to future domains. To fix over-adaptation, we propose a preemptive
gradient modification strategy. It preemptively adapts to future domains and
uses the acquired gradients to modify current adaptation, thereby preserving
the model's adaptability. In summary, we propose a stable continual test-time
adaptation (CTTA) framework for rPPG measurement, called \textbf{PhysRAP},
which \textbf{R}emembers the past, \textbf{A}dapts to the present, and
\textbf{P}reempts the future. Extensive experiments show its state-of-the-art
performance, especially in domain shifts. The code is available at
https://github.com/xjtucsy/PhysRAP.

</details>


### [3] [Evaluating New AI Cell Foundation Models on Challenging Kidney Pathology Cases Unaddressed by Previous Foundation Models](https://arxiv.org/abs/2510.01287)
*Runchen Wang,Junlin Guo,Siqi Lu,Ruining Deng,Zhengyi Lu,Yanfan Zhu,Yuechen Yang,Chongyu Qu,Yu Wang,Shilin Zhao,Catie Chang,Mitchell Wilkes,Mengmeng Yin,Haichun Yang,Yuankai Huo*

Main category: q-bio.QM

TL;DR: 评估2025年先进AI细胞基础模型在肾脏病理学中的细胞核分割性能，发现CellViT++ [Virchow]表现最佳，融合模型显著减少分割错误。


<details>
  <summary>Details</summary>
Motivation: 肾脏病理学中准确的细胞核分割对下游任务至关重要，但现有模型在形态多样性和成像变异性的肾脏组织上的效果尚不明确。

Method: 使用人类参与评分框架，在大型肾脏图像数据集上对比2025年先进AI细胞基础模型与2024年前模型，并进行融合集成评估和模型一致性分析。

Result: CellViT++ [Virchow]在2091个挑战样本中获得40.3%的"良好"评级，表现最佳；融合模型达到62.2%"良好"预测，仅0.4%"差"预测，显著改善分割质量。

Conclusion: AI细胞基础模型在肾脏病理学中具有巨大潜力，融合模型能有效解决先前研究未处理的挑战性案例，为肾脏特异性模型优化提供支持。

Abstract: Accurate cell nuclei segmentation is critical for downstream tasks in kidney
pathology and remains a major challenge due to the morphological diversity and
imaging variability of renal tissues. While our prior work has evaluated
early-generation AI cell foundation models in this domain, the effectiveness of
recent cell foundation models remains unclear. In this study, we benchmark
advanced AI cell foundation models (2025), including CellViT++ variants and
Cellpose-SAM, against three widely used cell foundation models developed prior
to 2024, using a diverse large-scale set of kidney image patches within a
human-in-the-loop rating framework. We further performed fusion-based ensemble
evaluation and model agreement analysis to assess the segmentation capabilities
of the different models. Our results show that CellViT++ [Virchow] yields the
highest standalone performance with 40.3% of predictions rated as "Good" on a
curated set of 2,091 challenging samples, outperforming all prior models. In
addition, our fused model achieves 62.2% "Good" predictions and only 0.4%
"Bad", substantially reducing segmentation errors. Notably, the fusion model
(2025) successfully resolved the majority of challenging cases that remained
unaddressed in our previous study. These findings demonstrate the potential of
AI cell foundation model development in renal pathology and provide a curated
dataset of challenging samples to support future kidney-specific model
refinement.

</details>


### [4] [MorphGen: Controllable and Morphologically Plausible Generative Cell-Imaging](https://arxiv.org/abs/2510.01298)
*Berker Demirel,Marco Fumero,Theofanis Karaletsos,Francesco Locatello*

Main category: q-bio.QM

TL;DR: MorphGen是一个基于扩散模型的荧光显微镜图像生成模型，能够跨多种细胞类型和扰动进行可控生成，通过匹配OpenPhenom的表型嵌入来保持生物学意义，并联合生成完整的荧光通道以保留细胞器结构。


<details>
  <summary>Details</summary>
Motivation: 加速基于高内涵图像的药物发现和基因编辑检测，需要模拟细胞对干预的响应。现有方法将多通道染色压缩为RGB图像会牺牲细胞器特异性细节。

Method: 使用扩散生成模型，通过对齐损失使其表示与OpenPhenom生物基础模型的表型嵌入匹配，联合生成完整的荧光通道而非压缩为RGB。

Result: 通过CellProfiler特征验证了与真实图像的生物学一致性，FID分数比之前的SOTA方法MorphoDiff降低了35%以上。

Conclusion: MorphGen能够生成生物学一致的荧光显微镜图像，保留细胞器结构细节，为药物发现和基因编辑提供有效的模拟工具。

Abstract: Simulating in silico cellular responses to interventions is a promising
direction to accelerate high-content image-based assays, critical for advancing
drug discovery and gene editing. To support this, we introduce MorphGen, a
state-of-the-art diffusion-based generative model for fluorescent microscopy
that enables controllable generation across multiple cell types and
perturbations. To capture biologically meaningful patterns consistent with
known cellular morphologies, MorphGen is trained with an alignment loss to
match its representations to the phenotypic embeddings of OpenPhenom, a
state-of-the-art biological foundation model. Unlike prior approaches that
compress multichannel stains into RGB images -- thus sacrificing
organelle-specific detail -- MorphGen generates the complete set of fluorescent
channels jointly, preserving per-organelle structures and enabling a
fine-grained morphological analysis that is essential for biological
interpretation. We demonstrate biological consistency with real images via
CellProfiler features, and MorphGen attains an FID score over $35\%$ lower than
the prior state-of-the-art MorphoDiff, which only generates RGB images for a
single cell type. Code is available at https://github.com/czi-ai/MorphGen.

</details>


### [5] [BioVERSE: Representation Alignment of Biomedical Modalities to LLMs for Multi-Modal Reasoning](https://arxiv.org/abs/2510.01428)
*Ching-Huei Tsou,Michal Ozery-Flato,Ella Barkan,Diwakar Mahajan,Ben Shapira*

Main category: q-bio.QM

TL;DR: BIOVERSE提出了一种两阶段方法，将预训练的生物医学基础模型与大型语言模型在共享嵌入空间中对齐，实现跨模态推理。


<details>
  <summary>Details</summary>
Motivation: 当前大型语言模型和生物医学基础模型在各自领域表现出色，但处于分离的嵌入空间，限制了跨模态推理能力。

Method: 采用两阶段方法：首先通过轻量级投影层将各模态独立对齐到共享LLM空间，然后通过多模态数据的指令微调实现下游推理。

Result: 在细胞类型注释、分子描述和蛋白质功能推理等任务中，紧凑的BIOVERSE配置超越了更大的LLM基线，同时比现有BioFMs产生更丰富的生成输出。

Conclusion: BIOVERSE为原则性多模态生物医学推理奠定了基础，实现了零样本注释、跨模态问答和交互式可解释对话。

Abstract: Recent advances in large language models (LLMs) and biomedical foundation
models (BioFMs) have achieved strong results in biological text reasoning,
molecular modeling, and single-cell analysis, yet they remain siloed in
disjoint embedding spaces, limiting cross-modal reasoning. We present BIOVERSE
(Biomedical Vector Embedding Realignment for Semantic Engagement), a two-stage
approach that adapts pretrained BioFMs as modality encoders and aligns them
with LLMs through lightweight, modality-specific projection layers. The
approach first aligns each modality to a shared LLM space through independently
trained projections, allowing them to interoperate naturally, and then applies
standard instruction tuning with multi-modal data to bring them together for
downstream reasoning. By unifying raw biomedical data with knowledge embedded
in LLMs, the approach enables zero-shot annotation, cross-modal question
answering, and interactive, explainable dialogue. Across tasks spanning
cell-type annotation, molecular description, and protein function reasoning,
compact BIOVERSE configurations surpass larger LLM baselines while enabling
richer, generative outputs than existing BioFMs, establishing a foundation for
principled multi-modal biomedical reasoning.

</details>


### [6] [Pharmacophore-Guided Generative Design of Novel Drug-Like Molecules](https://arxiv.org/abs/2510.01480)
*Ekaterina Podplutova,Anastasia Vepreva,Olga A. Konovalova,Vladimir Vinogradov,Dmitrii O. Shkil,Andrei Dmitrenko*

Main category: q-bio.QM

TL;DR: 提出了一种新的生成框架，在药物发现中平衡药效团相似性和结构多样性，通过案例研究验证了其在乳腺癌治疗中的适用性。


<details>
  <summary>Details</summary>
Motivation: 传统对接优化在生成方法中计算成本高且结果可能不准确，需要一种能平衡药效团相似性和结构多样性的新方法。

Method: 开发了一个生成框架，允许用户提供自定义参考集（如FDA批准药物），指导从头生成潜在治疗药物，平衡参考化合物的药效团相似性和活性分子的结构多样性。

Result: 生成的化合物保持对已知活性分子的高药效团保真度，同时引入显著的结构新颖性，显示出功能创新和可专利性的强大潜力。

Conclusion: 该方法在药物发现中具有稳健性和药学相关性，为早期药物发现提供了有效的生成框架。

Abstract: The integration of artificial intelligence (AI) in early-stage drug discovery
offers unprecedented opportunities for exploring chemical space and
accelerating hit-to-lead optimization. However, docking optimization in
generative approaches is computationally expensive and may lead to inaccurate
results. Here, we present a novel generative framework that balances
pharmacophore similarity to reference compounds with structural diversity from
active molecules. The framework allows users to provide custom reference sets,
including FDA-approved drugs or clinical candidates, and guides the \textit{de
novo} generation of potential therapeutics. We demonstrate its applicability
through a case study targeting estrogen receptor modulators and antagonists for
breast cancer. The generated compounds maintain high pharmacophoric fidelity to
known active molecules while introducing substantial structural novelty,
suggesting strong potential for functional innovation and patentability.
Comprehensive evaluation of the generated molecules against common drug-like
properties confirms the robustness and pharmaceutical relevance of the
approach.

</details>


### [7] [First passage times to T cell activation](https://arxiv.org/abs/2510.01694)
*Tony Wong,Ikchang Cho,Maria R. D'Orsogna,Tom Chou*

Main category: q-bio.QM

TL;DR: 开发了一个随机模型来研究T细胞在淋巴结中如何通过多阶段识别过程被抗原呈递细胞激活，分析了在非特异性APC干扰、T细胞降解和淋巴结退出情况下的激活概率和平均首次通过时间，并展示了动力学校对机制如何提高对特异性APC的选择性。


<details>
  <summary>Details</summary>
Motivation: 研究适应性免疫系统中T细胞如何有效识别外来抗原，特别是在存在非特异性抗原呈递细胞干扰、T细胞降解和淋巴结退出等复杂条件下，理解T细胞激活的机制和特异性。

Method: 建立了一个随机模型，将T细胞与APC的相互作用表示为多阶段马尔可夫链，T细胞只有在达到与特异性APC相关的终端状态时才能成功激活。计算了在干扰条件下的激活概率和平均首次通过时间，并引入了具有状态重置功能的动力学校对机制。

Result: 成功计算了在非特异性APC干扰、T细胞降解和淋巴结退出情况下的T细胞激活概率和平均首次通过时间，证明了动力学校对机制能够显著增强对特异性APC的选择性。

Conclusion: 多阶段识别过程和动力学校对机制共同作用，使T细胞能够在复杂环境中有效区分特异性APC，确保免疫系统对外来抗原的精确识别和响应。

Abstract: Effective recognition of foreign antigens by the adaptive immune system
relies on T cells being activated by antigen-presenting cells (APCs) in lymph
nodes. Here, diffusing T cells may encounter cognate APCs that present matching
antigen fragments or non-cognate ones that do not; they are also subject to
degradation. We develop a stochastic model in which T cell-APCs interact via a
sequence of recognition steps, represented as a multistage Markov chain. T
cells are successfully activated only if the terminal state associated with a
cognate APC is reached. We compute the probability of successful activation in
the presence of interfering non-cognate APCs, T cell degradation, and lymph
node exit, and analyze the mean first-passage time to activation. We also
incorporate a kinetic proofreading mechanism that enables state resetting, and
show how this enhances specificity toward cognate APCs.

</details>


### [8] [A Multicentric Dataset for Training and Benchmarking Breast Cancer Segmentation in H&E Slides](https://arxiv.org/abs/2510.02037)
*Carlijn Lems,Leslie Tessier,John-Melle Bokhorst,Mart van Rijthoven,Witali Aswolinskiy,Matteo Pozzi,Natalie Klubickova,Suzanne Dintzis,Michela Campora,Maschenka Balkenhol,Peter Bult,Joey Spronck,Thomas Detone,Mattia Barbareschi,Enrico Munari,Giuseppe Bogina,Jelle Wesseling,Esther H. Lips,Francesco Ciompi,Frédérique Meeuwsen,Jeroen van der Laak*

Main category: q-bio.QM

TL;DR: BEETLE数据集是一个用于乳腺癌H&E染色全玻片图像多类语义分割的数据集，包含587个活检和切除样本，涵盖所有分子亚型和组织学分级，特别关注现有数据集中代表性不足的形态学特征。


<details>
  <summary>Details</summary>
Motivation: 现有的乳腺癌分割公共数据集缺乏形态学多样性，无法支持模型泛化性和在异质性患者队列中的稳健生物标志物验证。

Method: 收集来自三个临床中心和两个公共数据集的587个样本，使用七种扫描仪数字化，采用多样化标注策略对四个类别（浸润性上皮、非浸润性上皮、坏死和其他）进行标注。

Result: 创建了一个涵盖所有分子亚型和组织学等级的多样化数据集，特别关注导管原位癌和分散性小叶肿瘤细胞等代表性不足的形态学特征。

Conclusion: BEETLE数据集的高多样性和与自动化生物标志物量化领域的相关性确保了其高重用潜力，并提供了精心策划的多中心外部评估集以实现标准化基准测试。

Abstract: Automated semantic segmentation of whole-slide images (WSIs) stained with
hematoxylin and eosin (H&E) is essential for large-scale artificial
intelligence-based biomarker analysis in breast cancer. However, existing
public datasets for breast cancer segmentation lack the morphological diversity
needed to support model generalizability and robust biomarker validation across
heterogeneous patient cohorts. We introduce BrEast cancEr hisTopathoLogy
sEgmentation (BEETLE), a dataset for multiclass semantic segmentation of
H&E-stained breast cancer WSIs. It consists of 587 biopsies and resections from
three collaborating clinical centers and two public datasets, digitized using
seven scanners, and covers all molecular subtypes and histological grades.
Using diverse annotation strategies, we collected annotations across four
classes - invasive epithelium, non-invasive epithelium, necrosis, and other -
with particular focus on morphologies underrepresented in existing datasets,
such as ductal carcinoma in situ and dispersed lobular tumor cells. The
dataset's diversity and relevance to the rapidly growing field of automated
biomarker quantification in breast cancer ensure its high potential for reuse.
Finally, we provide a well-curated, multicentric external evaluation set to
enable standardized benchmarking of breast cancer segmentation models.

</details>


### [9] [BioinfoMCP: A Unified Platform Enabling MCP Interfaces in Agentic Bioinformatics](https://arxiv.org/abs/2510.02139)
*Florensia Widjaja,Zhangtianyi Chen,Juexiao Zhou*

Main category: q-bio.QM

TL;DR: BioinfoMCP是一个统一平台，通过自动转换工具将现有生物信息学工具转换为MCP兼容服务器，解决了AI代理框架与生物信息学工具集成的问题。


<details>
  <summary>Details</summary>
Motivation: 生物信息学工具与新兴AI代理框架的集成存在接口不兼容、输入输出格式异构和参数约定不一致等障碍，手动转换数百个专业工具既费力又不可持续。

Method: BioinfoMCP包含两个组件：BioinfoMCP Converter使用大语言模型从工具文档自动生成稳健的MCP服务器；BioinfoMCP Benchmark系统验证转换工具在各种计算任务中的可靠性和多功能性。

Result: 构建了包含38个MCP转换生物信息学工具的平台，验证显示94.7%的工具在三个广泛使用的AI代理平台上成功执行复杂工作流。

Conclusion: BioinfoMCP通过消除AI自动化的技术障碍，实现了与复杂生物信息学分析的自然语言交互，无需大量编程专业知识，为智能、可互操作的计算生物学提供了可扩展路径。

Abstract: Bioinformatics tools are essential for complex computational biology tasks,
yet their integration with emerging AI-agent frameworks is hindered by
incompatible interfaces, heterogeneous input-output formats, and inconsistent
parameter conventions. The Model Context Protocol (MCP) provides a standardized
framework for tool-AI communication, but manually converting hundreds of
existing and rapidly growing specialized bioinformatics tools into
MCP-compliant servers is labor-intensive and unsustainable. Here, we present
BioinfoMCP, a unified platform comprising two components: BioinfoMCP Converter,
which automatically generates robust MCP servers from tool documentation using
large language models, and BioinfoMCP Benchmark, which systematically validates
the reliability and versatility of converted tools across diverse computational
tasks. We present a platform of 38 MCP-converted bioinformatics tools,
extensively validated to show that 94.7% successfully executed complex
workflows across three widely used AI-agent platforms. By removing technical
barriers to AI automation, BioinfoMCP enables natural-language interaction with
sophisticated bioinformatics analyses without requiring extensive programming
expertise, offering a scalable path to intelligent, interoperable computational
biology.

</details>


<div id='eess.IV'></div>

# eess.IV [[Back]](#toc)

### [10] [Median2Median: Zero-shot Suppression of Structured Noise in Images](https://arxiv.org/abs/2510.01666)
*Jianxu Wang,Ge Wang*

Main category: eess.IV

TL;DR: 提出了Median2Median（M2M）零样本去噪框架，专门针对结构化噪声设计，通过新颖的采样策略生成伪独立子图像对，无需干净标签数据即可有效去除相关噪声。


<details>
  <summary>Details</summary>
Motivation: 现实世界图像常被具有强各向异性相关的结构化噪声破坏，现有方法难以有效去除。数据驱动方法依赖高质量标签且泛化性有限，而零样本方法仅对独立同分布噪声有效。

Method: M2M引入方向性插值和广义中值滤波的采样策略，生成伪独立子图像对，采用随机分配策略扩大采样空间并消除系统偏差，适用于Noise2Noise训练。

Result: 在真实模拟研究中，M2M在独立同分布噪声下与最先进零样本方法性能相当，在相关噪声下始终优于这些方法。

Conclusion: M2M是结构化噪声抑制的高效、无数据解决方案，标志着零样本去噪首次突破严格独立同分布假设限制。

Abstract: Image denoising is a fundamental problem in computer vision and medical
imaging. However, real-world images are often degraded by structured noise with
strong anisotropic correlations that existing methods struggle to remove. Most
data-driven approaches rely on large datasets with high-quality labels and
still suffer from limited generalizability, whereas existing zero-shot methods
avoid this limitation but remain effective only for independent and identically
distributed (i.i.d.) noise. To address this gap, we propose Median2Median
(M2M), a zero-shot denoising framework designed for structured noise. M2M
introduces a novel sampling strategy that generates pseudo-independent
sub-image pairs from a single noisy input. This strategy leverages directional
interpolation and generalized median filtering to adaptively exclude values
distorted by structured artifacts. To further enlarge the effective sampling
space and eliminate systematic bias, a randomized assignment strategy is
employed, ensuring that the sampled sub-image pairs are suitable for
Noise2Noise training. In our realistic simulation studies, M2M performs on par
with state-of-the-art zero-shot methods under i.i.d. noise, while consistently
outperforming them under correlated noise. These findings establish M2M as an
efficient, data-free solution for structured noise suppression and mark the
first step toward effective zero-shot denoising beyond the strict i.i.d.
assumption.

</details>


<div id='q-bio.PE'></div>

# q-bio.PE [[Back]](#toc)

### [11] [Bayesian Re-Analysis of the Phylogenetic Topology of Early SARS-CoV-2 Case Sequences](https://arxiv.org/abs/2510.01484)
*Michael B. Weissman*

Main category: q-bio.PE

TL;DR: 作者指出Pekar等人2022年论文中的贝叶斯推理存在根本性错误，修正后结果显示SARS-CoV-2更可能是单次而非两次成功引入人类。


<details>
  <summary>Details</summary>
Motivation: 纠正Pekar等人2022年论文中关于SARS-CoV-2起源的贝叶斯分析错误，重新评估病毒引入人类的可能性。

Method: 重新分析Pekar论文中的贝叶斯推理，修正其中的根本性错误，重新计算单次和两次引入的似然性。

Result: 修正错误后，单次引入的似然性大于两次引入的似然性，与原文结论相反。

Conclusion: SARS-CoV-2更可能通过单次成功引入传播给人类，而非原文声称的两次引入。

Abstract: A much-cited 2022 paper by Pekar et al. claimed that Bayesian analysis of the
molecular phylogeny of early SARS-CoV-2 cases indicated that it was more likely
that two successful introductions to humans had occurred than that just one
had. Here I show that after correcting a fundamental error in Bayesian
reasoning the results in that paper give larger likelihood for a single
introduction than for two.

</details>
